IRulya Therapeutics Inc. SEC filings IRLA
IRulya Therapeutics Inc. has 462 filings in SEC EDGAR's recent list, going back to Jan 5, 2016. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 19, 2026 | Oct 19, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Oct 9, 2026 | Oct 7, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Oct 6, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 2, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Acquisition or sale of assets, Officer or director change
|
Sep 14, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Listing notice
|
Sep 4, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 27, 2026 | Aug 23, 2026 |
| 8-K |
Current report
Other events
|
Aug 17, 2026 | Aug 17, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 31, 2026 | Jul 29, 2026 |
| 8-K/A |
Amended current report
Other events
|
Jul 30, 2026 | May 17, 2026 |
| 8-K/A |
Amended current report
Change to shareholder rights
|
Jun 26, 2026 | Jun 26, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jun 26, 2026 | Jun 26, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Other events
|
May 21, 2026 | May 20, 2026 |
| 8-K/A |
Amended current report
Regulation FD disclosure
|
May 18, 2026 | May 17, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
May 18, 2026 | May 17, 2026 |
| 8-K |
Current report
Other events
|
Apr 28, 2026 | Apr 27, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 22, 2026 | Apr 22, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Apr 9, 2026 | Apr 9, 2026 |
| 8-K |
Current report
Agreement ended, Regulation FD disclosure
|
Mar 30, 2026 | Mar 27, 2026 |
| 8-K |
Current report
Listing notice
|
Mar 20, 2026 | Mar 16, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 12, 2026 | Feb 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 2, 2026 | Jan 30, 2026 |
| 8-K |
Current report
Other events
|
Jan 29, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 17, 2025 | Oct 17, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 26, 2025 | Sep 25, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 16, 2025 | Jul 16, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 13, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Other events
|
Nov 14, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Listing notice
|
Jun 21, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 15, 2024 | Feb 13, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 29, 2024 | Jan 23, 2024 |
| 8-K/A | Amended current report | Jan 5, 2024 | Oct 20, 2023 |
| 8-K |
Current report
Other events
|
Jan 3, 2024 | Dec 29, 2023 |
| 8-K |
Current report
Agreement ended
|
Dec 22, 2023 | Dec 22, 2023 |
| 8-K |
Current report
Listing notice
|
Dec 8, 2023 | Dec 4, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 26, 2023 | Oct 24, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Officer or director change
|
Oct 23, 2023 | Oct 20, 2023 |
| 8-K |
Current report
Material agreement, New debt, Officer or director change
|
Sep 6, 2023 | Aug 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 10, 2023 | Aug 4, 2023 |
| 8-K |
Current report
Material agreement, Results of operations, New debt, Unregistered share sale, Officer or director change, Regulation FD disclosure, Other events
|
Jul 24, 2023 | Jul 21, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 25, 2023 | May 24, 2023 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Apr 5, 2023 | Apr 5, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 28, 2023 | Mar 27, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 3, 2023 | Mar 1, 2023 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Other events
|
Jan 30, 2023 | Jan 24, 2023 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Jan 27, 2023 | Jan 24, 2023 |
| 8-K |
Current report
Listing notice
|
Dec 16, 2022 | Dec 13, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 30, 2022 | Sep 28, 2022 |
| 8-K |
Current report
Results of operations, Bylaw or fiscal year change, Other events
|
Aug 1, 2022 | Aug 1, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 22, 2022 | Jul 20, 2022 |
| 8-K |
Current report
Material agreement, New debt, Officer or director change, Shareholder vote results
|
Jun 10, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Acquisition or sale of assets, Officer or director change
|
May 20, 2022 | May 19, 2022 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Officer or director change
|
May 12, 2022 | May 7, 2022 |
| 8-K |
Current report
Other events
|
May 10, 2022 | May 9, 2022 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change
|
May 2, 2022 | Apr 26, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 15, 2022 | Mar 14, 2022 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Officer or director change, Other events
|
Feb 2, 2022 | Jan 28, 2022 |
| 8-K |
Current report
Other events
|
Jan 26, 2022 | Jan 25, 2022 |
| 8-K |
Current report
Material agreement
|
Dec 23, 2021 | Dec 23, 2021 |
| 8-K |
Current report
Other events
|
Oct 26, 2021 | Oct 26, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2021 | Jun 16, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
May 18, 2021 | May 13, 2021 |
| 8-K |
Current report
Other events
|
Feb 16, 2021 | Feb 12, 2021 |
| 8-K |
Current report
Officer or director change
|
Feb 10, 2021 | Feb 9, 2021 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 26, 2021 | Jan 26, 2021 |
| 8-K |
Current report
Officer or director change
|
Jan 25, 2021 | Jan 19, 2021 |
| 8-K |
Current report
Other events
|
Dec 4, 2020 | Dec 4, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2020 | Jun 8, 2020 |
| 8-K |
Current report
Officer or director change
|
May 21, 2020 | May 18, 2020 |
| 8-K |
Current report
Results of operations
|
May 12, 2020 | May 12, 2020 |
| 8-K |
Current report
Officer or director change
|
Apr 30, 2020 | Apr 27, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2020 | Mar 17, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 6, 2020 | Feb 5, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
May 13, 2019 | May 13, 2019 |
Showing 84 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IRLA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New Haven, CT
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1662774
- Former names
- Quince Therapeutics, Inc. (until Oct 9, 2026); Cortexyme, Inc. (until Aug 1, 2022)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.